AnaptysBio, Inc.

NASDAQ:ANAB

Biotechnology

Healthcare
$47.06 -1.88%

-$1.07 today

Market cap
$1.40B
Beta
0.41
P/E (TTM)
-59.7
EPS (TTM)
-$0.93
52W Low $11.40High $72.36

Volume 0.57M

Average 0.76M

Price history

AnaptysBio, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+90.76%

Period high

$69.81

Period low

$24.67

Latest

$47.06

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 12, 2026Nov 12, 2026
10-QNov 12, 2026Nov 12, 2026
4Oct 2, 2026Oct 2, 2026
10-KTSep 21, 2026Sep 21, 2026
8-KSep 21, 2026Sep 21, 2026
4Sep 17, 2026Sep 17, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
8-KAug 11, 2026Aug 11, 2026
4Aug 7, 2026Aug 7, 2026
4Aug 7, 2026Aug 7, 2026
8-KJul 30, 2026Jul 30, 2026
DEFA14AJun 29, 2026Jun 29, 2026
ARSJun 29, 2026Jun 29, 2026
DEF 14AJun 29, 2026Jun 29, 2026
8-KJun 22, 2026Jun 22, 2026

Competitors

Who does AnaptysBio, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ANAB's filings, answered from its disclosures.

What is the latest ANAB filing?

The latest filing shown is 8-K dated Nov 12, 2026.

How many recent filings does ANAB have?

Intrinsic Alpha currently shows 20 recent filings for ANAB.